Advertisement

ADVERTISEMENT

comparative effectiveness

Definitive vs Conservative Treatments for Older Men With Prostate Cancer
Videos
Definitive vs Conservative Treatments for Older Men With Prostate Cancer
02/24/2021
02/24/2021
Journal of Clinical Pathways
Enzalutamide vs Apalutamide, Darolutamide, and Bicalutamide for Nonmetastatic CRPC
Videos
Enzalutamide vs Apalutamide, Darolutamide, and Bicalutamide for Nonmetastatic CRPC
02/23/2021
02/23/2021
Journal of Clinical Pathways
Conference Coverage
Weekly vs Biweekly Cetuximab for Metastatic Colorectal Cancer
01/19/2021
01/19/2021
Journal of Clinical Pathways
News
Comparison of Costs, Outcomes Among Neoadjuvant-Adjuvant Treatment Strategies for Breast Cancer
12/08/2020
12/08/2020
Journal of Clinical Pathways
Conference Coverage
Watch and Wait vs Initial Treatment for Advanced FL
12/03/2020
12/03/2020
Journal of Clinical Pathways
News
Effective, Less Toxic Treatment Option Identified for Aggressive B-Cell Lymphoma
05/29/2020
Risk-adapted dose-adjusted etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab (DA-EPOCH-R) therapy is effective and well tolerated in adults with Burkitt lymphoma regardless of age or...
Risk-adapted dose-adjusted etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab (DA-EPOCH-R) therapy is effective and well tolerated in adults with Burkitt lymphoma regardless of age or...
...
05/29/2020
Journal of Clinical Pathways
News
Real-World HRU, Costs in Patients With MCL Treated With Drug Combo vs Chemoimmunotherapy
05/20/2020
Researchers recently compared health care resource utilization (HRU) and costs of relapsed or refractory (R/R) mantle cell lymphoma (MCL) patients treated with ibrutinib ± rituximab (I±R) or chemoimmunotherapy (CIT)...
Researchers recently compared health care resource utilization (HRU) and costs of relapsed or refractory (R/R) mantle cell lymphoma (MCL) patients treated with ibrutinib ± rituximab (I±R) or chemoimmunotherapy (CIT)...
...
05/20/2020
Journal of Clinical Pathways
News
High Risk of Preventable and Mitigable Adverse Events in Cancer Care
08/22/2017
JCP Editors
Researchers have identified a significant burden of adverse events across the cancer care continuum, including preventable or mitigable events, according to a study published in Cancer (online August 17, 2017;...
Researchers have identified a significant burden of adverse events across the cancer care continuum, including preventable or mitigable events, according to a study published in Cancer (online August 17, 2017;...
...
08/22/2017
Journal of Clinical Pathways
Research in Review
Resistance Mutations Predict Metastatic Patterns in NSCLC
08/17/2017
JCP Editors
Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research...
Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research...
...
08/17/2017
Journal of Clinical Pathways
Author Insights
Cost-Effective Alternative Identified for Autologous Stem Cell Mobilization in Multiple Myeloma
08/14/2017
Pavan Bhamidipati, MBBS, MD
In a randomized, open-label study, we discovered that tbo-filgrastim (Granix) can be used in the place of filgrastim (Neupogen) for autologous stem cell mobilization for multiple myeloma and non-Hodgkin’s lymphoma...
In a randomized, open-label study, we discovered that tbo-filgrastim (Granix) can be used in the place of filgrastim (Neupogen) for autologous stem cell mobilization for multiple myeloma and non-Hodgkin’s lymphoma...
In a...
08/14/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Psych Congress Regionals
July 18 ⁠–⁠ July 19
Advances in Inflammatory Bowel Disease Regionals
July 19 ⁠–⁠ July 20
July 24 ⁠–⁠ July 26
APP Institute Inflammatory Bowel Disease
July 26 ⁠–⁠ July 27
July 27 ⁠–⁠ July 28
July 27 ⁠–⁠ July 28
Psych Congress Regionals
August 8 ⁠–⁠ August 9
August 14 ⁠–⁠ August 17
APP Institute Dermatology
August 16 ⁠–⁠ August 17
August 16 ⁠–⁠ August 18
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use